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Abstract
Although genome-wide association studies (GWAS) of complex traits have yielded more reproducible associations than had
been discovered using any other approach, the loci characterized to date do not account for much of the heritability to such
traits and, in general, have not led to improved understanding of the biology underlying complex phenotypes. Using a web
site we developed to serve results of expression quantitative trait locus (eQTL) studies in lymphoblastoid cell lines from
HapMap samples (http://www.scandb.org), we show that single nucleotide polymorphisms (SNPs) associated with complex
traits (from http://www.genome.gov/gwastudies/) are significantly more likely to be eQTLs than minor-allele-frequency–
matched SNPs chosen from high-throughput GWAS platforms. These findings are robust across a range of thresholds for
establishing eQTLs (p-values from 10
24–10
28), and a broad spectrum of human complex traits. Analyses of GWAS data from
the Wellcome Trust studies confirm that annotating SNPs with a score reflecting the strength of the evidence that the SNP is
an eQTL can improve the ability to discover true associations and clarify the nature of the mechanism driving the
associations. Our results showing that trait-associated SNPs are more likely to be eQTLs and that application of this
information can enhance discovery of trait-associated SNPs for complex phenotypes raise the possibility that we can utilize
this information both to increase the heritability explained by identifiable genetic factors and to gain a better
understanding of the biology underlying complex traits.
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Introduction
Results of genome-wide association studies (GWAS) in complex
traits published to date have provided us with surprisingly little
new information on the nature of the genetic component to these
phenotypes, despite the large number of single nucleotide
polymorphisms (SNPs) found to be reproducibly associated with
such traits. In some cases, this reflects the fact that major aspects of
the biological basis for disease were already well understood;
results of GWAS in autoimmune disorders, for example, have
reinforced the central importance of the immune system and its
regulation. For a few disorders, results of GWAS have highlighted
biological contributing factors to disease that had not previously
been recognized as central, such as the complement system in
macular degeneration [1] or autophagy in Crohn’s disease [2–4].
While it does seem ungrateful to question the utility of GWAS
when they have yielded so many more reproducible associations
than we have achieved with any other approach, the fact is that
our primary goal in conducting GWAS for a complex trait –
achieving a comprehensive understanding of the genetic basis for
that trait – remains elusive for most of the traits that have been
examined. The failure to achieve this goal is made particularly
acute by the recognition that the loci that have been successfully
identified not only provide us with little insight into the genetic
basis for the trait, but also account for little of the overall
heritability [5]. Although there are important caveats to these grim
statistics – most published studies have conducted discovery
research in populations of European descent, and some important
disorders have not even been examined using GWAS yet – the
collective experience has led to sharp disagreement as to whether
there is sufficient value in targeting near-term investments in
genomics to GWAS, or whether such investments are better
targeted to sequencing [6–8]. The key issue in this controversy is
whether the genetic risk factors not yet discovered are largely
similar in frequency and effect size to those that have been
discovered using GWAS (i.e. common alleles with low risk) or are,
instead, rarer alleles that would be best identified through
sequencing studies.
Studies we report here suggest that we have not yet exhausted
the signals that can be discovered through GWAS. Annotating
SNPs with information on expression can improve our ability to
more easily distinguish those associations likely to be replicated,
and provide us with a better understanding of the genes and
mechanisms driving the associations we discover. Moreover, it
appears that for at least a subset of complex disorders, there are
many more common variants truly associated with disease and
highly likely to be expression quantitative trait loci (eQTLs). These
variants can be identified and characterized using existing GWAS
and tools such as the SCAN database (SNP and Copy number
ANnotation; http://www.scandb.org) [9].
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SNPs Associated with Complex Traits Are More Likely to
Be eQTLs than Frequency-Matched SNPs from GWAS
Platforms
The 1598 SNPs characterized in the GWAS catalog [10] as
showing association with complex traits included 625 that would
be classified as eQTLs with a p-value threshold of 10
24 using
CEPH (Centre d’Etude du Polymorphisme Humain) samples of
European descent from Utah (CEU) or 972 using the combined
sample of the CEU plus the Yoruban samples from Ibadan Nigeria
(YRI) data to define eQTLs, 46 (83 for the combined CEU+YRI)
that would be classified as eQTLs with a p-value threshold of 10
26
and 17 (18 for the combined CEU+YRI) that would be classified
as eQTLs with a p-value threshold of 10
28. As summarized in
Figure 1, we observed significantly more eQTLs among these
1598 trait-associated SNPs than expected given their minor allele
frequency (MAF) distribution. Given that many gene transcript
levels show substantial correlations, it is, perhaps, not surprising
that we also observed that SNPs associated with many transcripts
(sometimes called eQTL hot spots or master regulators) were also
enriched among trait-associated SNPs. Using a more stringent
definition for defining trait-associated SNPs (up to 10
28) reduced
their absolute numbers of such SNPs, but increased the
significance of the observed enrichment of eQTLs among trait-
associated SNPs.
There was some redundancy among the set of SNPs examined
through the GWAS catalog because different published reports
can highlight different (but correlated) SNPs for the same
phenotypes, and also because several phenotypes may show
associations to some of the same sets of SNPs (e.g. autoimmune
disorders with associations to HLA region SNPs and PTPN22). To
insure that our conclusions were robust to both linkage
disequilibrium (LD) among the cataloged SNP set and which of
any correlated set of SNPs were retained for analyses, we
conducted simulations in which we retained only one of any
SNP set with r
2.0.3 and for each replicate conducted 100
simulations conditional on MAF as for Figure 1 (see Materials and
Methods for simulation details). The eQTL enrichment was
preserved in LD-pruned sets of cataloged variants, for eQTL
definition thresholds with p,10
24 or smaller.
Table 1 summarizes the information on eQTLs for SNPs (with
MAF.0.05) on high throughput platforms, associated with traits
in the GWAS catalog, and associated with phenotypes selected to
represent those for which lymphoblastoid cell lines (LCLs) might
be expected to be a poor proxy for the human tissues most relevant
for disease (neurological/psychiatric phenotypes, cancers) and
those for which LCLs might be expected to be a good proxy for
the human tissues most relevant to disease (autoimmune
disorders). As is apparent from the table, neurological and
psychiatric phenotypes as well as cancers (regardless of tumor
site) showed levels of enrichment similar to those observed for the
overall trait-associated SNP set, although as expected, autoim-
mune disorders showed somewhat greater levels of enrichment.
Division of the GWAS catalog SNPs into those identified through
studies on autoimmune disorders and those identified through
studies on other complex traits reveals that the apparent
enrichment of eQTLs (defined at a threshold of p,10
26) detected
through studies on LCLs is indeed significantly greater
(p=0.00011) for SNPs identified through studies in autoimmune
disorders than for SNPs identified through studies of other traits.
Using eQTL Information Improves Ability to Identify
Reproducible Signals in GWAS
In order to understand the practical utility of our observation
that trait-associated SNPs are more likely to be eQTLs, we
examined in more detail results summaries from the Wellcome
Trust Case Control Consortium (WTCCC) GWAS [11], using the
data on Crohn’s disease as a primary example application. If SNPs
associated with Crohn’s disease are no more likely than non-
associated SNPs to be eQTLs, we would expect the proportion of
SNPs associated with Crohn’s disease at p,.01 in bins defined
according to eQTL function score (see Materials and Methods for
definition of eQTL function score) to be constant (the overall
proportion of Crohn’s p-values smaller than .01 is .0152). Instead,
as illustrated in Figure 2, we found that there were 357 SNPs
associated with Crohn’s disease among the 10,000 SNPs with the
highest eQTL function scores; the expected number, based on 100
simulations conditioned on MAF for these 10,000 SNPs was 117–
178. No such enrichment was observed for other ways of
prioritizing SNPs for function, including missense SNPs (the
proportion of non-synonymous SNPs with Crohn’s association
p,0.01 was 0.0152), coding-synonymous substitutions (0.0253), or
intronic SNPs (0.0158). We then differentiated the SNPs as ‘‘cis-
regulators’’ (these are eQTLs for genes that are within 4 Mb) and
‘‘trans-regulators’’ (these are eQTLs for genes that are more than
4 Mb away or on a different chromosome). The Bonferroni
adjustment of significance was different for the cis- and trans-
regulators (see Materials and Methods). The enrichment was
preserved in the SNPs classified as cis-regulators but was not
evident in the SNPs classified as trans-regulators, suggesting that
cis-regulatory effects were more likely to be present among the
Crohn’s associated SNPs.
We observed a similar enrichment if we start with the SNPs
most strongly associated with Crohn’s disease and ask whether
there was enrichment for SNPs with high eQTL function scores.
As illustrated in Figure 3, in the top 1000 Crohn’s associated SNPs
we observed 392 with eQTL functional scores larger than 1 (the
expected number based on all HapMap scores is 183.5), 324 SNPs
with scores larger than 2 (143.5 expected by chance) and 172 with
scores larger than 3 (with only 18.6 expected by chance). Among
these 172 SNPs we observed some, such as in STAT3, that have
been confirmed in replication studies.
Analyses on other phenotypes from the WTCCC association
studies [11] confirmed that our proposed annotations benefit
phenotypes beyond Crohn’s disease. Figure 4 illustrates that both
type 1 diabetes (T1D) and rheumatoid arthritis (RA) had
significantly more SNPs than expected with phenotype associa-
tions (p,.01) among the 10,000 SNPs with top eQTL function
scores. To insure that these results were not driven by strong LD
among SNPs in the major histocompatibility complex (MHC)
region, we repeated the analyses for all Wellcome Trust
Author Summary
We show here that single nucleotide polymorphisms
(SNPs) associated with complex traits (as identified in the
catalog of results from genome-wide association studies
http://www.genome.gov/gwastudies/) are more likely than
other SNPs chosen from high-throughput genotyping
platforms to predict expression levels of genes. These
observations confirm that genetic risk factors for complex
traits will often affect phenotype by altering the amount or
timing of protein production, rather than by changing the
type of protein produced. This knowledge can be used to
improve our ability to discover genetic risk factors for
complex traits and to improve our understanding of their
underlying biology.
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Using eQTLs from CEU+YRI # SNPs eQTL p-value threshold 10
24 eQTL p-value threshold 10
26
Platform SNPs (MAF ..05) 1,213,906 595,285 (.490) 29,347 (.024)
All Catalog SNPs 1598 972 (0.608) 83 (0.052)
Autoimmune Disorders 259 165 (0.637) 21 (0.081)
Cancers 93 56 (0.602) 4 (0.043)
Neurological/Psychiatric Disorders 63 41 (0.651) 2 (0.032)
Using eQTLs from CEU only
Platform SNPs (MAF ..05) 1,213,906 345,249 (.284) 12,749 (.011)
All Catalog SNPs 1598 625 (0.391) 46 (0.029)
Autoimmune Disorders 259 116 (0.448) 17 (0.066)
Cancers 93 30 (0.323) 3 (.032)
Neurological/Psychiatric Disorders 63 20 (0.317) 1 (0.016)
SNPs from the NHGRI catalog were classified according to the type of disease leading to their inclusion as a trait-associated SNP to investigate whether eQTLs identified
in LCLs are more enriched in disorders for which LCLs are more likely to be an appropriate tissue match for the disease. Studies were conducted separately using eQTLs
identified in the combined CEU+YRI samples (upper lines), and those identified only in the CEU (lower lines). Only SNPs with MAF .0.05 are included in these studies,
and eQTL p-value thresholds of 10
24 and 10
26 are shown.
doi:10.1371/journal.pgen.1000888.t001
Figure 1. Trait-associated SNPs are more likely to be eQTLs. The distribution of the number of eQTLs (defined as p,10
24 left panel, p,10
26
middle panel, and p,10
28 right panel) observed for each of 1,000 draws of 1,598 SNPs from bins matched for minor allele frequency to the 1,598
SNPs downloaded from the NHGRI catalog (bins include all SNPs in the Illumina 1M and Affymetrix 6.0 products) is shown in the bar graphs, with the
actual number of eQTLs observed in the 1,598 SNPs from the NHGRI catalog shown as a solid circle.
doi:10.1371/journal.pgen.1000888.g001
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substantially similar results. Figure 5 highlights the enrichment of
functional SNPs (eQTL function scores larger than 3) among the
SNPs with the strongest associations to disease in the scans for
T1D and RA (not unexpected given results in Figure 4), but also
for hypertension and bipolar disease. There is little evidence for
enrichment of eQTLs among top signals for coronary artery
disease (CAD) or type 2 diabetes (T2D). These results suggest that
for at least some complex traits, a more efficient prioritization for
replication studies can be achieved by incorporating the expression
scores, and that there may be many more SNPs that are truly
associated with disease and also likely to be eQTLs than we have
identified through GWAS to date.
Discussion
Our results build on those of previous studies, particularly those
of Schadt and colleagues [12–15] that focused on using
transcriptome information to improve understanding of genetic
signals, but the rapid accumulation of trait-associated SNPs
through GWAS, coupled with the systematic efforts to catalog
these variants [10,16] has enabled us to generalize the concept that
information on eQTLs will have utility for understanding the
genetic component to complex traits. Our primary observations –
that SNPs reproducibly associated with complex human traits are
more likely to be eQTLs – are novel, although perhaps not
unexpected given that few of even those SNPs most reproducibly
associated with complex traits have been attributed to missense or
nonsense variants. Our subsequent observations made in associ-
ation studies in which we annotated SNPs with eQTL informa-
tion, imply that at least some complex disorders have substantial
numbers of undiscovered susceptibility loci that can be more easily
discovered and characterized by annotating SNPs with informa-
tion on eQTL scores. This is also a novel observation. Moreover,
use of information on expression appears to benefit our
understanding of not only more tractable disorders, such as
Figure 2. SNPs with the highest eQTL function scores are enriched for WTCCC Crohn’s susceptibility loci. SNPs were ordered according
to their eQTL function scores from most significant to least significant and divided in groups of 10,000. Only the data from the first 13 groups is
shown (as 13 index bins along the X-axis) because fewer than 130K SNPs have expression scores larger than zero. Each point in the graph
corresponds to eQTL function score bins and the y-axis shows the number of SNPs in each bin that have WTCCC Crohn’s GWAS p-values less than
0.01. The horizontal line illustrates the expectation based on the observed number of SNPs in the whole GWAS that have p-values smaller than 0.01.
The proportion of the remaining SNPs with p smaller than 0.01 is 0.014. The dotted lines represent estimated 95% confidence bands obtained using
simulations.
doi:10.1371/journal.pgen.1000888.g002
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large numbers of loci have already been identified at the cost of
genotyping 10,000 or fewer samples, but also for less tractable
disorders such as hypertension and bipolar disease, for which
fewer associations have been characterized despite the large
numbers of genotyped samples (.29,000 in GWAS and .34,000
for replication in studies of hypertension [17]).
Use of expression information should move us closer to that
elusive goal of developing a more comprehensive understanding of
the genetic basis for complex traits in two ways: (1) by identifying
and characterizing a larger number of contributing loci, we should
be better able to discern the key biological functions affected by
genetic risk factors and (2) SNP signals may be more accurately
characterized with respect to target genes and mechanism of effect,
further enhancing our ability to discern relevant biological
functions. Thus, our results provide a strong additional rationale
for the inclusion of eQTL information in the annotation of SNPs
from GWAS. Moreover, even the analyses we have completed to
characterize trait-associated SNPs as being more likely than allele
frequency matched SNPs from the same platform to be eQTLs
have revealed information about the potential biological rationale
for some of the observed associations. For example, an intronic
SNP, rs3129934, on chromosome 6 that is a cis-acting eQTL for
multiple HLA transcripts with a high eQTL functional score (24.9)
shows the strongest association with T1D in the MHC region in
the WTCCC study [11] and is also the SNP most strongly
associated with increased risk for multiple sclerosis (MS) in a
pooling-based GWAS [18].
A variety of the approaches we used in conducting these studies
should be of general utility in enrichment studies. It is clear, for
example, that the MAF spectrum of SNPs associated with complex
human traits is quite different than that of SNPs on the products
used to conduct GWAS, or in the overall HapMap. The much
higher minor allele frequencies observed for SNPs reproducibly
associated with complex traits than for SNPs on high throughput
platforms is a natural consequence of the increased power to detect
associations for SNPs with higher minor allele frequencies. It is
clearly critical to condition on the MAF in enrichment studies in
which simulations are conducted using SNPs from high through-
put platforms or from the HapMap, and to date, this has not been
Figure 3. SNPs with the strongest evidence for association in WTCCC Crohn’s disease are more likely to have eQTL function scores
.3. SNPs have been ordered according to their WTCCC Crohn’s association p-values from the most to the least significant, and divided in groups of
10,000. For each group bin of 10,000 trait-associated SNPs, the number of SNPs with expression score larger than 3 was calculated and the results are
shown in the scatterplot. The horizontal line illustrates the expectation based on the observed eQTL function scores in all SNPs in the WTCCC Crohn’s
dataset. The dotted lines represent estimated 95% confidence bands obtained using simulations.
doi:10.1371/journal.pgen.1000888.g003
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further complicating factor in conducting enrichment studies. We
are confident that failure to adequately account for LD will not
affect our estimate of the proportion of SNPs that are eQTLs, but
rather the variance of this estimate. There are, however, more
subtle biases related to LD that might have affected our studies.
For example, true associations may be more easily detected in
regions of the genome with high LD because these regions are
more likely to have good coverage on high throughput platforms
for GWAS. Although it is unclear that this would bias results of
our studies, it is important to note that these types of subtle biases
can affect results of enrichment studies in unpredictable ways.
The challenges of conducting eQTL studies are also widely
appreciated. The eQTLs identified in array-based transcriptome
studies in LCLs are likely to be a limited subset of the eQTLs that
will ultimately be identified using more sensitive techniques in
comprehensive collections of human tissues. Moreover, a variety of
studies have highlighted the potential sensitivity of eQTL studies
to cell and tissue subtypes [15,19,20]. Although several studies
have suggested that eQTLs will be largely tissue specific [21,22],
others note that substantial numbers of eQTLs are shared across
tissues [15,23]. Similarly, some have found that LCLs are prone to
such high levels of non-genetic variability (growth parameters,
EBV levels, ATP levels, etc.) that they might be considered
unreliable for genomic studies [24], while others highlight the
reproducibility of results of transcriptome studies [25,26] and find
that LCLs show little variability as a consequence of non-genetic
factors [27].
To the degree that the transcriptome is a reflection of the local
and temporal environment, it could be argued that eQTLs
identified in generic studies will have little value for enhancing
understanding of complex trait studies unless eQTLs are identified
Figure 4. SNPs with the highest eQTL function scores are enriched for WTCCC T1D and RA susceptibility loci. The plots show results of
eQTL enrichment analyses for the remaining Wellcome Trust phenotypes beginning with SNPs having the highest expression scores (similar to
analyses for Crohn’s disease summarized in Figure 2). SNPs have been ordered according to their expression score from most significant to least
significant and divided in groups of 10,000. Only the data from the first 13 groups is shown. The six plots correspond to the six other diseases
investigated in the initial WTCCC GWAS. The dotted lines represent estimated 95% confidence bands obtained using simulations.
doi:10.1371/journal.pgen.1000888.g004
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trait studies. Our results provide little support for such arguments,
and instead highlight the utility of LCLs as a reasonable model for
the study of expression. And while LCLs are clearly not the ideal
tissue for expression studies in many complex disorders, we note
that we plan to serve results of eQTL studies in a variety of tissues
in SCAN, and consider the studies summarized in this manuscript
to be an initial effort that will be enriched by subsequent studies in
additional tissues. It is possible that diseases without evidence for
eQTL enrichment using data from LCLs will ultimately yield such
evidence when data from more relevant tissues is used;
alternatively, at least a subset of those disorders without evidence
for enrichment for eQTLs may turn out to derive substantial
heritability from rare variants. In any case, results of our studies
clearly support additional investment in eQTL identification in
other tissues, as well as in the development of public access
databases and software tools, such as those in SCAN (http://www.
scandb.org), that allows results of such studies to be productively
used by the scientific community.
Materials and Methods
SNPs Reproducibly Associated with Complex Human
Traits
The National Human Genome Research Institute (NHGRI) has
collected the results of published GWA studies in a publicly
available online database (http://www.genome.gov/gwastudies)
[16]. This catalog is continually updated; the version we utilize for
the present study was downloaded on June 29, 2009. We used the
NHGRI default set of SNPs reported to be associated to complex
Figure 5. SNPs with the strongest evidence for association with WTCCC T1D, RA, hypertension, and bipolar disorder are more likely
to have eQTL function scores .3. The plots show results of eQTL enrichment analysis for the remaining Wellcome Trust phenotypes beginning
with the SNPs most strongly associated with disease (similar to analyses for Crohn’s disease summarized in Figure 3). For each disease, SNPs have
been ordered according to their association p-values from the most to the least significant, and divided in groups of 10,000. For each group, the
number of SNPs with expression score larger than 3 was calculated and the results are shown in the scatterplots. The horizontal lines illustrate the
expectation based on the observed scores in all SNPs in the relevant WTCCC dataset. The dotted lines represent estimated 95% confidence bands
obtained using simulations.
doi:10.1371/journal.pgen.1000888.g005
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25 for all figures and tables in the
manuscript, but we note that results show more significant
enrichment for more stringent definitions for trait-associated SNPs
(we tested 10
25 through 10
28).
The SCAN Database
We have created an online database to serve the results of our
gene-expression studies in LCLs. SCAN (SNP and Copy number
ANnotation database; http://www.scandb.org) can be queried
through either the SNP or gene to retrieve information on the
relationship between SNPs and transcript levels at user-specified p-
value thresholds [9]. SCAN enables batch queries of genes to
retrieve a list of SNPs that predict the expression of the genes at a
user-specified threshold. SCAN also holds multi-locus disequilib-
rium measures [28] to summarize reported LD information
among SNPs and to characterize coverage of genes by the high-
throughput genotyping platforms.
The expression data served in SCAN had been assayed in
HapMap LCLs (87 CEU and 89 YRI) with the Affymetrix
GeneChip Human Exon 1.0 ST Array [29]. The exon array
measures both exon-level and gene-level expression, includes
approximately 1.4 million probesets, and profiles over 17,000 gene
transcripts.
Genome-wide association analyses of 13,080 transcript clusters
(gene-level) with reliable expression and more than 2 million SNPs
in the CEU or YRI populations were conducted using the
Quantitative Trait Disequilibrium Test (QTDT) [30]. A transcript
cluster or probeset in the exon array is defined as reliably
expressed in LCLs if the log2-transformed expression signal is
greater than 6 in at least 80% of the 176 HapMap samples
included analyses. Each transcript cluster includes a set of
probesets (exon-level) containing all known exons and 59- and
39- untranslated regions (UTRs) in the genome. In contrast to
other arrays (e.g., U95 and U133 series arrays), the probes on the
exon array cover entire gene regions and not just 39-UTRs.
Since SNPs in probes can generate spurious eQTL signals by
affecting hybridization, we downloaded SNP data from dbSNP
(build 129, human genome assembly build 36) to identify probes in
probesets that hybridize to regions containing SNPs. The genomic
coordinates of the probes were downloaded from the Affymetrix
website (http://www.affymetrix.com). We filtered these probes
before conducting the expression analyses generating the results
served in SCAN.
Analysis of eQTL Enrichment
All analyses have been conducted using all available information
(eQTLs for both CEU and YRI samples) and also using only
information from the CEU samples. Results are substantially
similar, but because most GWAS reported to date have been
conducted in samples of recent European descent, and to be
conservative, summary figures use only the eQTL information
from the CEU samples. We also provide details for some of the key
eQTL studies in tabular form (Table 1), where we provide
summary information for enrichment studies using CEU+YRI
eQTL data and for enrichment studies using only the CEU eQTL
data.
The MAF distribution for SNPs showing reproducible associ-
ations with complex human traits is markedly different from the
MAF distribution for all SNPs on the high density SNP genotyping
platforms, or the minor allele frequency distribution of SNPs
included on high throughput platforms used for GWAS (Figure
S1). Thus, any study focused on enrichments among SNPs
reproducibly associated with complex human phenotypes must be
conditioned on MAF. To enable us to conduct simulations
conditional on MAF, we constructed MAF bins as follows: allele
frequencies were calculated from HapMap genotype data on the
CEU. Only the parents’ genotypes were included in the frequency
calculations since the children’s alleles are not independent. We
used the toolkit PLINK [31] to calculate frequencies. We classified
SNPs on Affymetrix Genome-Wide Human SNP Array 6.0 and
Illumina’s High Density Human 1M-Duo into non-overlapping
minor allele frequency (MAF) bins, each of width .05, using the
MAFs of the SNPs in the CEU samples, as most of the published
reports summarized in the NHGRI catalog are from GWAS on
individuals of recent European descent.
We conducted simulations to test for an enrichment of eQTLs
among the NHGRI variants associated with complex traits by
generating 1000 randomized SNP sets Si each of the same size as
the original NHGRI list (1598) containing variants matched on
MAF distribution, sampled without replacement from the set of
typed SNPs on each high-throughput platform, which had been
grouped into discrete MAF bins. For each set, we determined the
number of eQTLs, Qi, at a p-value threshold. We tested the
robustness of the eQTL enrichment across a range of p-value
thresholds (10
28 to 10
24), as shown in Figure 1. These simulations
(N=1000) yield an empirical p-value, calculated as the proportion
of simulations in which the number of eQTLs exceeds the
observed number, Q, in the NHGRI list.
Because some GWAS report associations for SNPs that were
interrogated through imputation rather than direct genotyping, we
repeated the analysis described above except that we used the
entire set of HapMap SNPs to generate the 1000 randomized SNP
sets with MAF matched to catalog SNPs, rather than only the
SNPs included on high throughput GWAS platforms. Results of
these studies show an even more significant enrichment of eQTLs
among catalog SNPs (Figure S2). Thus, we focus in this paper on
the more conservative results obtained using the simulations
generated from SNPs on high-throughput GWAS platforms.
To investigate whether the eQTL enrichment we observe in the
NHGRI variants is driven by linkage disequilibrium (LD), an LD-
pruned SNP set was generated from the NHGRI list using r
2,0.3.
We then performed an eQTL enrichment analysis on this set,
using a permutation procedure on 100 randomized sets of SNPs
that reflect the LD-pruned set’s MAF distribution. To show that
the eQTL enrichment is not dependent on the particular LD-
pruned set chosen, we generated 100 such LD-pruned sets on each
of which 100 simulations were performed, as just described (Figure
S3).
Master Regulator Enrichment Analysis
A similar enrichment analysis was simultaneously conducted on
the number of master regulators, defined as eQTLs which control
the expression of at least 10 genes at a given expression p-value. As
before, this analysis was done across a range of p-values thresholds
(10
28 to 10
24) to establish robustness. We also investigated
whether the enrichment of master regulators or eQTL hot spots in
the NHGRI list depends crucially on the number of target genes
(10, 50, 100, 1000) in the definition (Figure S4).
Assessing Robustness across Phenotype
It is widely appreciated that LCLs are not likely to be faithful
models for gene expression in all tissues. To assess whether our
findings for the associated SNPs from the NHGRI catalog were
driven by enrichment in a few of the diseases for which LCLs
might be reasonable proxies for tissues most strongly implicated in
disease, we examined separately results for all disorders for which
brain is the likely focus of disease (neurological and psychiatric
disorders), all cancer phenotypes, since it might be hypothesized
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autoimmune disorders for which LCLs are, arguably, a reasonable
proxy for tissue relevant to the disease process. Results are
summarized in Table 1. We also tested whether the level of
enrichment for eQTLs (defined using p,10
26 in studies on the
CEU) in SNPs identified in studies on autoimmune disorders was
significantly different from the level of enrichment for eQTLs in
SNPs identified in studies of all other disorders using a chi-square
test with 1 df.
Expression Score for Annotating SNPs
Given the results of our studies on the SNPs reproducibly
associated with complex traits, we reasoned that prioritizing follow
up of SNPs discovered to show phenotype associations through
GWAS should be improved by adding eQTL information to the
physical and publicly available functional information commonly
used for SNP annotation. Thus, we constructed a score for each
SNP that quantifies the likelihood that the SNP has a function (or
in strong LD with a functional SNP) in regulating transcript levels.
Using the SCAN db file that has annotation information for each
SNP (location, host gene, function, CEU MAF) as well as
summaries of eQTL p-values (minimum cis p-value, minimum
overall p-value), we focused on the 3,844,039 unique autosomal
SNPs. The eQTL p-values were truncated at 0.01 for cis-
regulatory SNPs (360,696 SNPs with p-value,0.01) and 0.0001
for trans-regulatory SNPs (1,883,759 SNPs). We define a cis-
regulatory SNP as a SNP that is within 4 MB of the beginning or
end of the gene with which the SNP shows transcript level
association, and we define a trans-regulatory SNP as a SNP that is
.4 MB from (or on another chromosome than) any gene with
which the SNP shows transcript level association.
In order to devise a one-dimensional score that summarizes as
much of the eQTL signal information as possible for prioritizing
GWAS signals according to their ‘‘functionality’’, we first note that
neither the scale of the score nor the distribution of the score for
non-functional SNPs are relevant – just the appropriate ranking of
SNPs with a function in regulating transcript levels. The building
blocks for the SNP score are: po which is the overall smallest
eQTL p-value (it can be either cis or trans), pc which is the smallest
cis p-value, No which is the overall number of transcripts used in
the analysis, and Nc which is the number of cis transcripts (i.e. the
number of transcripts annotated to genes in the vicinity of the SNP
under investigation). The score we propose:
S~max({log10 (No|po),{log10 (Nc|pc), 0),
builds on Bonferroni corrections applied separately for trans and
cis signals (there are 13,080 transcripts used in the analysis). Note
that the scores are truncated at zero.
Utilizing Expression Information in GWAS
In order to determine whether our newly derived functional
score can aid in identifying associations likely to be replicated, we
first examined the summary data for Crohn’s disease from the
WTCCC association study [11] (downloaded when results data
were publicly available). After QC (less than 5% missing data,
good clustering), we filtered SNPs at a 1% MAF threshold, and
removed markers with no rs ID, leaving 391,878 SNPs. We
matched these SNPs using the rs IDs within the SCAN database,
leaving us with 386,306 SNPs.
We then ordered the SNPs according to their score S from
largest to smallest score. The top SNPs based on the eQTL score
show an excess of small association p-values with Crohn’s disease
(for example, in the top ten SNPs, six have p-values smaller than
0.01).
We divided the SNPs into groups of 10,000 (in the order of their
eQTL scores) and counted the number of SNPs in each group
with p,0.01 for association with Crohn’s disease - see Figure 2
(there are just over 123K SNPs with scores larger than 0). The first
10,000 SNPs (ranked according to eQTL function score) include
357 with Crohn’s association p-values smaller than 0.01. We
simulated sets of SNPs with allele frequencies matching the top
10,000 and, in 100 simulations, the range of this statistic (number
of p-values smaller than 0.01) is 117–178 which is far less than the
observed number.
We also examined enrichment for eQTLs in the Crohn’s disease
data by ordering the SNPs showing association to Crohn’s, and
examined the proportion of SNPs with eQTL scores .3, .2, and
.1 among the top 1000 SNPs for Crohn’s disease (Figure 3).
We repeated the Crohn’s disease enrichment studies in the
other WTCCC phenotypes. As with Crohn’s disease, we first
conducted analyses checking for an excess of small association p-
values in the SNPs that have high expression annotation scores
(Figure 4). Finally, we ranked the SNPs according to their
association p-values and looked for an enrichment of high
expression scores (Figure 5).
To insure that results of enrichment studies were not unduly
influenced by large numbers of correlated SNPs in the MHC
region with high eQTL scores, we repeated the analyses
summarized in Figure 2 and Figure 4 after removing all SNPs
on chromosome 6 (see Figure S5). Results were relatively
unchanged.
Supporting Information
Figure S1 Minor allele frequency (MAF) distributions for
Affymetrix 6.0 SNPs (A), Illumina 1M SNPs (B), and NHGRI
Associated SNPs (C).
Found at: doi:10.1371/journal.pgen.1000888.s001 (1.57 MB TIF)
Figure S2 (A) The distribution of the number of eQTLs (at
p,10
24 observed for each of 1,000 draws of 1,598 SNPs from bins
matched for minor allele frequency to the 1,598 SNPs downloaded
from the NHGRI catalog (bins include all HapMap SNPs) is
shown in the bar graphs, with the actual number of eQTLs
observed in the 1,598 SNPs from the NHGRI catalog shown as a
solid circle. (B) Identical to Figure 1, leftmost panel, with analysis
as above, except that SNPs for the simulation were drawn from
SNPs on high-throughput GWAS panels.
Found at: doi:10.1371/journal.pgen.1000888.s002 (2.69 MB
TIF)
Figure S3 Observed numbers of eQTLs among all trait-
associated SNPs trimmed for LD are shown as solid black circles
with the bar graph showing the distribution of eQTLs among
SNPs chosen at random from the same allele frequency bins from
among all SNPs included on high-throughput GWAS products.
Enrichment of eQTLs among trait-associated SNPs is preserved
even in the absence of LD among trait-associated SNPs.
Found at: doi:10.1371/journal.pgen.1000888.s003 (2.09 MB TIF)
Figure S4 Observed numbers of master regulators among all
trait-associated SNPs are indicated by the solid black circles and
the distribution of the number of master regulators (defined as
SNPs predicting 10 transcripts and SNPs predicting 100
transcripts, both for p,10
24) observed in 1,000 draws of 1,598
SNPs from minor-allele-frequency-matched bins (including all
SNPs on Illumina 1M and Affymetrix 6.0 products) is plotted in
the bar graphs.
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Figure S5 This is similar to Figure 2, except that all SNPs on
chromosome 6 have been removed from calculations, demon-
strating that the Crohn’s enrichment for eQTLs is not dependent
on SNPs in the HLA region. Results were similar for T1D and
RA.
Found at: doi:10.1371/journal.pgen.1000888.s005 (0.88 MB TIF)
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